DeepCrystal (acquired)
DeepCrystal provides AI-powered solutions for the pharmaceutical industry. The core technology is an AI platform applying machine learning to pharma workflows. The company targeted B2B customers in pharma, offering a platform-based approach for drug discovery and development. Its technology was acquired by Numerate in the summer of 2017. The market context centers on pharma companies seeking scalable, data-driven platform partnerships.
DeepCrystal (acquired)
DeepCrystal provides AI-powered solutions for the pharmaceutical industry. The core technology is an AI platform applying machine learning to pharma workflows. The company targeted B2B customers in pharma, offering a platform-based approach for drug discovery and development. Its technology was acquired by Numerate in the summer of 2017. The market context centers on pharma companies seeking scalable, data-driven platform partnerships.